Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS46000986BKPyvENSG00000116984.15protein_codingMTRNoNo4548Q99707
TVIS30087171HIVENSG00000116984.15protein_codingMTRNoNo4548Q99707
TVIS30026952HIVENSG00000116984.15protein_codingMTRNoNo4548Q99707
TVIS20047945HPVENSG00000116984.15protein_codingMTRNoNo4548Q99707
TVIS20037351HPVENSG00000116984.15protein_codingMTRNoNo4548Q99707
TVIS20048036HPVENSG00000116984.15protein_codingMTRNoNo4548Q99707
TVIS20015959HPVENSG00000116984.15protein_codingMTRNoNo4548Q99707
TVIS44012711HTLV-1ENSG00000116984.15protein_codingMTRNoNo4548Q99707
TVIS44002677HTLV-1ENSG00000116984.15protein_codingMTRNoNo4548Q99707
TVIS44048647HTLV-1ENSG00000116984.15protein_codingMTRNoNo4548Q99707
TCGA Plot Options
Drug Information
GeneMTR
DrugBank IDDB00116
Drug NameTetrahydrofolic acid
Target IDBE0000734
UniProt IDQ99707
Regulation Typecofactor
PubMed IDs10978155; 11169015; 11237340; 9398303; 9730838
CitationsHall DA, Jordan-Starck TC, Loo RO, Ludwig ML, Matthews RG: Interaction of flavodoxin with cobalamin-dependent methionine synthase. Biochemistry. 2000 Sep 5;39(35):10711-9.@@Fowler B: The folate cycle and disease in humans. Kidney Int Suppl. 2001 Feb;78:S221-9.@@Fu TF, di Salvo M, Schirch V: Enzymatic determination of homocysteine in cell extracts. Anal Biochem. 2001 Mar;290(2):359-65.@@Jarrett JT, Choi CY, Matthews RG: Changes in protonation associated with substrate binding and Cob(I)alamin formation in cobalamin-dependent methionine synthase. Biochemistry. 1997 Dec 16;36(50):15739-48.@@Jarrett JT, Hoover DM, Ludwig ML, Matthews RG: The mechanism of adenosylmethionine-dependent activation of methionine synthase: a rapid kinetic analysis of intermediates in reductive methylation of Cob(II)alamin enzyme. Biochemistry. 1998 Sep 8;37(36):12649-58.
GroupsNutraceutical
Direct ClassificationGlutamic acid and derivatives
SMILESNC1=NC(=O)C2=C(NCC(CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)N2)N1
PathwaysHistidinemia; Lesch-Nyhan Syndrome (LNS); Molybdenum Cofactor Deficiency; Azathioprine Action Pathway; AICA-Ribosiduria; Purine Nucleoside Phosphorylase Deficiency; Methionine Adenosyltransferase Deficiency; Folate Malabsorption, Hereditary; Adenine Phosphoribosyltransferase Deficiency (APRT); Thioguanine Action Pathway; Mercaptopurine Action Pathway; Non-Ketotic Hyperglycinemia; Methotrexate Action Pathway; Betaine Metabolism; S-Adenosylhomocysteine (SAH) Hydrolase Deficiency; Glycine and Serine Metabolism; Adenosine Deaminase Deficiency; Xanthinuria Type II; Methionine Metabolism; Dihydropyrimidine Dehydrogenase Deficiency (DHPD); Histidine Metabolism; Cystathionine beta-Synthase Deficiency; Folate Metabolism; Sarcosine Oncometabolite Pathway; Sarcosinemia; Methylenetetrahydrofolate Reductase Deficiency (MTHFRD); Purine Metabolism; Gout or Kelley-Seegmiller Syndrome; Adenylosuccinate Lyase Deficiency; Ammonia Recycling
PharmGKBPA164745110
ChEMBLCHEMBL2021342